Nicholas West

Nicholas West

Auto-generated profile, based on publicly available information

Nicholas West

BC Children's Hospital Research Institute Vancouver British Columbia Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2018 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Open access
PDF file
ALAaron Lau
Aaron Lau
NLNasim Lowlaavar
Nasim Lowlaavar
ECErin M. Cooke
Erin M. Cooke
NWNicholas West
Nicholas West
AGAlexandra German
Alexandra German
RMRichard N. Merchant
Richard N. Merchant
The purpose of this study was to evaluate the effects of preoperative forced-air warming on intraoperative hypothermia.

1 October 2018 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
NWNicholas West
Nicholas West
KHKlaske van Heusden
Klaske van Heusden
Matthias GörgesMatthias Görges
Matthias Görges
SBSonia Brodie
Sonia Brodie
ARAryannah Rollinson
Aryannah Rollinson
RMRichard N. Merchant
Richard N. Merchant
BACKGROUND: Closed-loop control of anesthesia involves continual adjustment of drug infusion rates according to measured clinical effect. The NeuroSENSE monitor provides an electroencephalographic measure of depth of hypnosis (wavelet-based anesthetic value for central nervous system monitoring [WAVCNS]). It has previously been used as feedback for closed-loop control of propofol, in a system designed using robust control engineering principles, which implements features specifically designed to ensure patient safety. Closed-loop control of a second drug, remifentanil, may be added to improve WAVCNSstability in the presence of variable surgical stimulation. The objective of this study was to design and evaluate the feasibility of a closed-loop system for robust control of propofol and remifentanil infusions using WAVCNSfeedback, with an infusion safety system based on the known pharmacological characteristics of these 2 drugs.METHODS: With Health Canada authorization, research ethics board approval, and informed consent, American Society of Anesthesiologists I–III adults, requiring general anesthesia for elective surgery, were enrolled in a 2-phase study. In both phases, infusion of propofol was controlled in closed loop during induction and maintenance of anesthesia, using WAVCNSfeedback, but bounded by upper- and lower-estimated effect-site concentration limits. In phase I, remifentanil was administered using an adjustable target-controlled infusion and a controller was designed based on the collected data. In phase II, remifentanil was automatically titrated to counteract rapid increases in WAVCNS.RESULTS: Data were analyzed for 127 patients, of median (range) age 64 (22–86) years, undergoing surgical procedures lasting 105 (9–348) minutes, with 52 participating in phase I and 75 in phase II. The overall control performance indicator, global score, was a median (interquartile range) 18.3 (14.2–27.7) in phase I and 14.6 (11.6–20.7) in phase II (median difference, −3.25; 95% confidence interval, −6.35 to −0.52). The WAVCNSwas within ±10 of the setpoint for 84.3% (76.6–90.6) of the maintenance of anesthesia in phase I and 88.2% (83.1–93.4) in phase II (median difference, 3.7; 95% confidence interval, 0.1–6.9). The lower propofol safety bound was activated during 30 of 52 (58%) cases in phase I and 51 of 75 (68%) cases in phase II.CONCLUSIONS: Adding closed-loop control of remifentanil improved overall controller performance. This controller design offers a robust method to optimize the control of 2 drugs using a single sensor. The infusion safety system is an important component of a robust automated anesthesia system, but further research is required to determine the optimal constraints for these safe conditions.

23 December 2019 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
NWNicholas West
Nicholas West
NCNancy Christopher
Nancy Christopher
KSKirsten Stratton
Kirsten Stratton
Matthias GörgesMatthias Görges
Matthias Görges
ZBZoë Brown
Zoë Brown

1 January 2018 in IEEE Journal of Translational Engineering in Health and Medicine
Verified
Journal Article
Open access
LFLuisa Flohr
Luisa Flohr
SBShaylene Beaudry
Shaylene Beaudry
KJK Taneille Johnson
K Taneille Johnson
NWNicholas West
Nicholas West
CBCatherine M Burns
Catherine M Burns
Matthias GörgesMatthias Görges
Matthias Görges
The pediatric intensive care unit (ICU) is a complex environment, in which a multidisciplinary team of clinicians (registered nurses, respiratory therapists, and physicians) continually observe and evaluate patient information. Data are provided by multiple, and often physically separated sources, cognitive workload is high, and team communication can be challenging. Objective: Our aim is to combine information from multiple monitoring and therapeutic devices in a mobile application, the VitalPAD, to improve the efficiency of clinical decision-making, communication, and thereby patient safety. Methods: We observed individual ICU clinicians, multidisciplinary rounds, and handover procedures for 54 hours to identify data needs, workflow, and existing cognitive aid use and limitations. A prototype was developed using an iterative participatory design approach; usability testing, including general and task-specific feedback, was obtained from 15 clinicians. Results: Features included map overviews of the ICU showing clinician assignment, patient status, and respiratory support; patient vital signs; a photo-documentation option for arterial blood gas results; and team communication and reminder functions. Discussion: Clinicians reported the prototype to be an intuitive display of vital parameters and relevant alerts and reminders, as well as a user-friendly communication tool. Future work includes implementation of a prototype, which will be evaluated under simulation and real-world conditions, with the aim of providing ICU staff with a monitoring device that will improve their daily work, communication, and decision-making capacity. Mobile monitoring of vital signs and therapy parameters might help improve patient safety in wards with single-patient rooms and likely has applications in many acute and critical care settings.

28 October 2015 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
TSTerri Sun
Terri Sun
NWNicholas West
Nicholas West
JAJ Mark Ansermino
J Mark Ansermino
CMCarolyne J Montgomery
Carolyne J Montgomery
DMDorothy Myers
Dorothy Myers
CBCarl L Von Baeyer
Carl L Von Baeyer

8 February 2019 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
KHKlaske van Heusden
Klaske van Heusden
KSKristian Soltesz
Kristian Soltesz
ECErin Cooke
Erin Cooke
SBSonia Brodie
Sonia Brodie
NWNicholas West
Nicholas West
GDGuy Dumont
Guy Dumont
Objective: The goal of this paper was to optimize robust PID control for propofol anesthesia in children aged 5-10 years to improve performance, particularly to decrease the time of induction of anesthesia while maintaining robustness. Methods: We analyzed results of a previous study conducted by our group to identify opportunities for system improvement. Allometric scaling was introduced to reduce the interpatient variability and a new robust PID controller was designed using an optimization-based method. We evaluated this optimized design in a clinical study involving 16 new cases. Results: The optimized controller design achieved the performance predicted in simulation studies in the design stage. Time of induction of anesthesia was median [Q1, Q3] 3.7 [2.3, 4.1] min and the achieved global score was 13.4 [9.9, 16.8]. Conclusion: Allometric scaling reduces the interpatient variability in this age group and allows for improved closed-loop performance. The uncertainty described by the model set, the predicted closed-loop responses, and the predicted robustness margins are realistic. The system meets the design objectives of improved speed of induction of anesthesia while maintaining robustness and improving clinically relevant system behavior. Significance: Control system optimization and ongoing system improvements are essential to the development of a clinically relevant commercial device. This paper demonstrates the validity of our approach, including system modeling, controller optimization, and pre-clinical testing in simulation.